Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823914 · ClinicalTrials.gov registry record
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 116
- Enrollment target
NCT00823914: Completed study, sponsored by Massachusetts General Hospital.
NCT00823914 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00823914 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
Objective of the study is to create and validate Chronic Quality of Life (CQOL) index that explores habits, career paths and other life choices psoriasis patients make as a result of coping with their disease that may not be impacted by therapy implemented at a given point in time. \- The investigators think this data will show that patients who were diagnosed at a young age will have worse chronic quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00823914
The ClinicalTrials.gov registry entry for NCT00823914 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00823914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00823914 about?
NCT00823914 is a clinical study titled "Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life". Objective of the study is to create and validate Chronic Quality of Life (CQOL) index that explores habits, career paths and other life choices psoriasis patients make as a result of coping with their disease that may not be impacted by therapy implemented at a given point in time. \- The investiga...
What is the current status of trial NCT00823914?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2008-12. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00823914?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.